[b]CERP >>>ROIDAL GAZELLE NEWZZZ//MASSIVE Q1 REVZZZ >>Cereplast Reports Preliminary First Quarter 2013 Revenue Results: Exceeds Revenue for Entire 2012 Fiscal Year[/b]
2013-04-17 08:00 ET - News Release
EL SEGUNDO, Calif., April 17, 2013 (GLOBE NEWSWIRE) -- Cereplast, Inc. (OTCQB:CERP) (the "Company"), a leading manufacturer of proprietary biobased, compostable and sustainable bioplastics, today announced preliminary revenue for the first quarter ended March 31, 2013. Cereplast expects to report 2013 first quarter revenue of approximately $900,000 to $1 million, exceeding total revenue for the entire 2012 fiscal year.
According to management, approximately 65% of this revenue was generated in Italy due to the demand created by the recently published Application Decree, which requires merchants to discontinue the use of traditional single-use plastic bags in favor of bioplastic bags or other alternatives. Sanctions for non-compliance will be enforced beginning the end of May 2013 and management estimates that as a result, the Company will experience an increase in demand for its Cereplast Compostables® blown film resins during the second half of 2013 as merchants are forced to transition to bioplastic alternatives.
Based on certain provisions, including current competition, current production capacity, a full production staff and sufficient working capital, management estimates that the Company's total addressable opportunity for Italy alone exceeds $50 million annually out of a total addressable market for compostable blown film grades in the country that exceeds $500 million per year.
Cereplast Chairman and CEO Mr. Frederic Scheer commented, "We are pleased with our encouraging preliminary revenue results during the first quarter of 2013 and are optimistic for the remainder of 2013. In Italy alone, we conservatively estimate our market opportunity to be approximately $50 million. Additionally, we expect other European nations to enact similar mandates which will exponentially increase our opportunity in Europe. We are excited about these favorable trends and will provide future updates as significant events occur.
About Cereplast, Inc.
Cereplast, Inc. (OTCQB:CERP) designs and manufactures proprietary biobased, sustainable bioplastics which are used as substitutes for traditional plastics in all major converting processes - such as injection molding, thermoforming, blow molding and extrusions - at a pricing structure that is competitive with traditional plastics. On the cutting-edge of biobased plastic material development, Cereplast now offers resins to meet a variety of customer demands. Cereplast Compostables® resins are ideally suited for single-use applications where high biobased content and compostability are advantageous, especially in the food service industry. Cereplast Sustainables® resins combine high biobased content with the durability and endurance of traditional plastic, making them ideal for applications in industries such as automotive, consumer electronics and packaging. Learn more at www.cereplast.com. You may also visit the Cereplast social networking pages at Facebook.com/Cereplast, Twitter.com/Cereplast and Youtube.com/Cereplastinc.
Safe Harbor Statement
Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance, the impact on the national and local economies resulting from terrorist actions, and U.S. actions subsequently; and other factors detailed in reports filed by the Company.
CONTACT: Cereplast, Inc.
Public Relations
Nicole Robertson
(310) 615-1900 x154
nrobertson@cereplast.com
Investor Relations:
Alliance Advisors, LLC
Alan Sheinwald
914-669-0222
asheinwald@allianceadvisors.net
Valter Pinto
914-669-0222 x201
valter@allianceadvisors.net
www.AllianceAdvisors.net
CERP ROIDAL GAZELLE NEWZZZ//MASSIVE Q1 REVZZZ Cereplast
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Hims & Hers Health Faces Revenue Challenges and Legal Issues
Hims & Hers Revenue Challenges Amid Stock Decline In recent trading sessions, Hims & Hers Health reported notable stock fluctuations as the company unveiled a decline in revenue per customer linked to its customization of GLP-1 medications for weight loss. This announcement caused an almost 11% drop in the stock price. Impacts of Collaboration Termination This steep...
Continue Reading
Entrée Resources Reports Solid Results for Q3 2025
Entrée Resources Ltd. Overview Entrée Resources Ltd. (TSX: ETG; OTCQB: ERLFF), a reputable Canadian mining company focused on the Oyu Tolgoi project, has announced its interim financial results for the third quarter of 2025. This announcement sheds light on its ongoing operations and future plans, emphasizing the company's significant role in one of the world's largest...
Continue Reading
Bucket List Wine Dinners Beckon to Los Angeles
Sipping on the Extraordinary: LA Wine Soiree When was the last time you had a glass of wine that truly feels like you've unlocked a treasure chest? That's what LearnAboutWine.com is going for with their bucket list wine dinners in Los Angeles. Imagine tasting some of the world's most coveted bottles, all served with a level of polish that screams high-end dining. Led by...
Continue Reading
BioLife Solutions Enhances Growth Potential with $73 Million Sale
BioLife Solutions Announces $73 Million Sale of SciSafe In a significant move aimed at reinforcing its strategic direction, BioLife Solutions, Inc. (NASDAQ: BLFS), a prominent player in the development and supply of cell processing tools and services for the cell and gene therapy market, has announced the sale of its biostorage subsidiary, SciSafe Holdings, Inc. The...
Continue Reading
Advancements in Universal Vaccine Development by Dx&Vx
Innovative Pathway Towards a Universal COVID-19 Vaccine In the wake of a global resurgence of COVID-19, Dx&Vx (DXVX) is stepping up its efforts to develop a universal vaccine aimed at providing protection against all variants of the virus. With the recent acquisition of cutting-edge technology, this next-generation vaccine is set to attract significant global interest....
Continue Reading